当前位置:首页 - 行情中心 - 美康生物(300439) - 财务分析 - 现金流量表

美康生物

(300439)

  

流通市值:30.17亿  总市值:39.66亿
流通股本:2.92亿   总股本:3.84亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金860,677,123.23387,037,100.61,921,359,967.361,495,571,934.32
  收到的税费返还68,961.4668,944.038,271,688.912,820,854.82
  收到其他与经营活动有关的现金79,610,740.6428,609,126.6560,789,903.8337,711,126.56
  经营活动现金流入小计940,356,825.33415,715,171.281,990,421,560.11,536,103,915.7
  购买商品、接受劳务支付的现金473,111,941.7236,409,559.98867,378,939.67854,912,154.57
  支付给职工以及为职工支付的现金208,789,868.37134,568,255.37385,869,242.06295,288,039.58
  支付的各项税费55,689,250.9228,519,886.73106,535,732.688,820,205
  支付其他与经营活动有关的现金106,479,848.7562,476,657.79232,825,498.12188,043,893.4
  经营活动现金流出小计844,070,909.74461,974,359.871,592,609,412.451,427,064,292.55
  经营活动产生的现金流量净额96,285,915.59-46,259,188.59397,812,147.65109,039,623.15
二、投资活动产生的现金流量:
  收回投资收到的现金516,000,000173,000,000934,710,000443,710,000
  取得投资收益收到的现金19,211,494.74384,460.563,990,185.531,608,780.25
  处置固定资产、无形资产和其他长期资产收回的现金净额575,594.3493,071.534,321,144.645,600
  处置子公司及其他营业单位收到的现金净额-023,970,733.9718,191,433.97
  收到的其他与投资活动有关的现金-015,015,53016,353,995.17
  投资活动现金流入小计535,787,089.08173,477,532.061,012,007,594.1479,909,809.39
  购建固定资产、无形资产和其他长期资产支付的现金64,682,728.2744,143,555.31420,537,843.7178,855,234.13
  投资支付的现金539,999,900222,000,0001,118,500,000694,000,000
  取得子公司及其他营业单位支付的现金-00672,808.34
  支付其他与投资活动有关的现金-080,000-
  投资活动现金流出小计604,682,628.27266,143,555.311,539,117,843.7873,528,042.47
  投资活动产生的现金流量净额-68,895,539.19-92,666,023.25-527,110,249.6-393,618,233.08
三、筹资活动产生的现金流量:
  吸收投资收到的现金480,000480,000100,0001,850,000
  其中:子公司吸收少数股东投资收到的现金480,000480,000100,0001,850,000
  取得借款收到的现金-030,000,00030,000,000
  收到其他与筹资活动有关的现金2,214,00001,981,058.41-
  筹资活动现金流入小计2,694,000480,00032,081,058.4131,850,000
  偿还债务支付的现金30,000,00030,000,00057,040,00057,040,000
  分配股利、利润或偿付利息支付的现金30,396,853.19289,214.1352,473,757.6752,905,542.21
  其中:子公司支付给少数股东的股利、利润-00-
  支付其他与筹资活动有关的现金8,337,046.53018,986,342.39-
  筹资活动现金流出小计68,733,899.7230,289,214.13128,500,100.06109,945,542.21
  筹资活动产生的现金流量净额-66,039,899.72-29,809,214.13-96,419,041.65-78,095,542.21
四、汇率变动对现金及现金等价物的影响-390,807.3-39,862.028,121.71,154,988.32
五、现金及现金等价物净增加额-39,040,330.62-168,774,287.99-225,709,021.9-361,519,163.82
  加:期初现金及现金等价物余额726,615,036.35726,615,036.35952,324,058.25952,324,058.25
  期末现金及现金等价物余额687,574,705.73557,840,748.36726,615,036.35590,804,894.43
补充资料:
  净利润55,608,076.33-262,674,724.72-
  资产减值准备3,708,061.03--2,991,776.71-
  固定资产和投资性房地产折旧70,232,741.92-182,439,587.26-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧70,232,741.92-182,439,587.26-
  无形资产摊销6,905,974.6-11,751,275.02-
  长期待摊费用摊销9,908,798.46-12,654,106.09-
  处置固定资产、无形资产和其他长期资产的损失-6,305.93-665,892.86-
  固定资产报废损失229,450.91-2,197,794.56-
  公允价值变动损失-226,892.6--81,517.67-
  财务费用534,208.34-4,962,804.24-
  投资损失-2,342,205.59--14,458,479.33-
  递延所得税-17,382,798.1--7,288,565.21-
  其中:递延所得税资产减少-11,788,040.4--5,218,375.7-
    递延所得税负债增加-5,594,757.7--2,070,189.51-
  存货的减少34,237,850.25--33,597,364.29-
  经营性应收项目的减少-29,650,474.1-16,714,442.5-
  经营性应付项目的增加-42,018,634.9--67,177,759.79-
  其他-1,096,138.72-13,332,761.68-
  不涉及现金收支的投资和筹资活动金额其他项目--34,360,271.62-
  现金的期末余额687,574,705.73-726,615,036.35-
  减:现金的期初余额726,615,036.35-952,324,058.25-
  现金及现金等价物的净增加额-39,040,330.62--225,709,021.9-
公告日期2025-08-292025-04-262025-04-192024-10-26
审计意见(境内)标准无保留意见
TOP↑